Key Takeaways From Acadia Healthcare Co Analyst Ratings
Portfolio Pulse from Benzinga Insights
Acadia Healthcare Co (NASDAQ: ACHC) has received mixed analyst ratings over the past quarter, with a range of price targets and recommendations. The average 12-month price target has decreased by 9.87% to $85.62. Analysts have adjusted their ratings and price targets based on recent company performance and market conditions.
July 02, 2024 | 3:01 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Acadia Healthcare Co has received a mix of analyst ratings, with some lowering their price targets. The average 12-month price target has decreased by 9.87% to $85.62, indicating a cautious outlook from analysts.
The mixed analyst ratings and the decrease in the average price target suggest a cautious outlook for Acadia Healthcare Co. While some analysts maintain positive ratings, the overall sentiment appears to be more reserved, reflecting recent company performance and market conditions.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100